Cryosurgery for prostate cancer: New technology and indications

被引：28

作者：

Benoit R.M. ^{[1
]}

Cohen J.K. ^{[1
]}

Miller R.J. ^{[1
]}

机构：

[1] Department of Urology, Allegheny General Hospital, 1209 Allegheny Tower, 625 Stanwix Street, Pittsburgh, 15222, PA

来源：

Current Urology Reports | 2000年 / 1卷 / 1期

关键词：

Androgen Deprivation Therapy; External Beam Radiotherapy; Localize Prostate Cancer; Prostate Cancer; Radical Prostatectomy;

D O I：

10.1007/s11934-000-0034-0

中图分类号：

学科分类号：

摘要：

Patients diagnosed with prostate cancer who elect to pursue active treatment of their disease must choose among the many available treatment alternatives. Several treatment options now exist for similar-stage disease (clinical T1-3N0M0), including radical prostatectomy, external beam radiation, prostate brachytherapy (PB), and cryosurgical ablation of the prostate (CSAP). This article reviews the current role of CSAP in the treatment of clinically localized prostate cancer. CSAP has a role in the primary treatment of men with high-risk, clinically localized prostate cancer (defined as PSA >10, Gleason score ≥ 7, or clinical stage ≥ cT2B). CSAP (occasionally followed by external beam radiotherapy) appears to offer improved rates of cancer control over other types of single or combination therapies for this high-risk prostate cancer, and it is associated with an acceptable side-effect profile. CSAP should also be the treatment of choice for men with recurrent local disease who have undergone external beam radiotherapy or PB. © 2000, Current Science Inc.

引用

页码：41 / 47

页数：6

共 35 条

[21]

Polascik T.J., Pound C.R., DeWeese T.L., Et al., Comparison of radical prostatectomy and Iodine 125 interstitial radiotherapy for the treatment of clinically localized prostate cancer: a 7-year biochemical (PSA) progression analysis, Urology, 51, pp. 884-890, (1998)

[22]

Ramos C.G., Carvahal G.F., Smith D.S., Et al., Retrospective comparison of radical retropubic prostatectomy and 125Iodine brachytherapy for localized prostate cancer, J Urol, 161, pp. 1212-1215, (1999)

[23]

Pisters L.L., von Eschenbach A.C., Technique, results, and complications of “modern” prostate cryotherapy, AUA Update Series, 15, pp. 297-304, (1996)

[24]

Rogers E., Ohori M., Kassabian V.S., Et al., Salvage radical prostatectomy: outcome measured by serum prostate specific antigen levels, J Urol, 153, pp. 104-110, (1995)

[25]

Pontes J.E., Montie J., Klein E., Et al., Salvage surgery for radiation failure in prostate cancer, Cancer, 71, pp. 976-980, (1993)

[26]

Badalament R.A., Bahn D.K., Kim J., Et al., Patient-reported complications after cryoablation therapy for prostate cancer, Urology, 54, pp. 295-300, (1999)

[27]

Recastle J.C., Sandison G.A., Saliken J.C., Donnelly B.J., McKinnon J.G., Considerations during clinical operation of two commercially available cryomachines, J Surg Oncol, 71, pp. 106-111, (1999)

[28]

Chin J.L., Downey D.B., Mulligan M., Fenster A., Three-dimensional transrectal ultrasound guided cryoablation for localized prostate cancer in nonsurgical candidates: a feasibility study and report of early results, J Urol, 159, pp. 910-914, (1998)

[29]

Vellet A.D., Saliken J., Donellly B., Et al., Prostatic cryosurgery: use of MR imaging in evaluation of success and technical modifications, Radiology, 203, pp. 653-659, (1997)

[30]

Tatsutani K., Rubinsky B., Onik G., Dahiya R., Effect of thermal variables on frozen human primary prostatic adenocarcinoma cells, Urology, 48, pp. 441-487, (1996)

← 1 2 3 4 →